Intravenous Insulin therapy is considered the best approach for managing hyperglycemia in critical patients but once patient starts oral feeds bolus insulin is required and therefore it is essential to switch the patients to subcutaneous insulin therapy. The gene discussed is INS; the disease is Hyperglycemia.